Skip to content

Clinical trials

Completed Adrenoleukodystrophy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adrenoleukodystrophy Status: Completed Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20122
20132
20161
20172
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Masonic Cancer Center, University of Minnesota4
Genetix Biotherapeutics Inc.2
Children's Hospital of Philadelphia1
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
Minoryx Therapeutics, S.L.1
Mirum Pharmaceuticals, Inc.1
New York Medical College1
Orpheris, Inc.1
Stanford University1
University of Florida1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adrenoleukodystrophy14
Leukodystrophy, Globoid Cell6
Leukodystrophy, Metachromatic6
Peroxisomal Disorders4
Wolman Disease4
Fucosidosis3
Gangliosidosis, GM13
Mucopolysaccharidosis I3
Sandhoff Disease3
Tay-Sachs Disease3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.